Table 3. Top 10 cancer incidence in Beijing, China, 2008-2012.
| Rank | Both |
Male |
Female |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Site | Cases | Incidence (1/105) | % | ASR | Site | Cases | Incidence (1/105) | % | ASR | Site | Cases | Incidence (1/105) | % | ASR | |||
| 1 | Female breast (C50) | 18,632 | 59.87 | 10.52 | 36.29 | Lung (C33-C34) | 23,116 | 73.29 | 25.21 | 40.06 | Breast (C50) | 18,632 | 59.87 | 21.82 | 36.29 | ||
| 2 | Lung (C33-C34) | 37,104 | 59.21 | 20.95 | 31 | Colorectum (C18-C21) | 11,284 | 35.78 | 12.31 | 19.85 | Lung (C33-C34) | 13,988 | 44.95 | 16.38 | 22.54 | ||
| 3 | Colorectum (C18-C21) | 20,361 | 32.49 | 11.5 | 17.36 | Liver (C22) | 9,111 | 28.89 | 9.94 | 17.08 | Colorectum (C18-C21) | 9,077 | 29.17 | 10.63 | 15.02 | ||
| 4 | Liver (C22) | 12,410 | 19.81 | 7.01 | 11.24 | Stomach (C16) | 7,578 | 24.03 | 8.27 | 13.08 | Thyroid (C73) | 4,536 | 14.58 | 5.31 | 10.2 | ||
| 5 | Stomach (C16) | 11,252 | 17.96 | 6.35 | 9.53 | Prostate (C61) | 4,966 | 15.75 | 5.42 | 7.76 | Uterus (C54-C55) | 4,480 | 14.4 | 5.25 | 8.65 | ||
| 6 | Prostate (C61) | 4,966 | 15.75 | 2.8 | 7.76 | Esophagus (C15) | 4,842 | 15.35 | 5.28 | 8.42 | Stomach (C16) | 3,674 | 11.81 | 4.3 | 6.24 | ||
| 7 | Uterus (C54-C55) | 4,480 | 14.4 | 2.53 | 8.65 | Bladder (C67) | 4,511 | 14.3 | 4.92 | 7.76 | Ovary (C56) | 3,386 | 10.88 | 3.96 | 6.72 | ||
| 8 | Kidney (C64-C66,68) | 7,120 | 11.36 | 4.02 | 6.58 | Kidney (C64-C66,68) | 4,276 | 13.56 | 4.66 | 8.12 | Liver (C22) | 3,299 | 10.6 | 3.86 | 5.55 | ||
| 9 | Ovary (C56) | 3,386 | 10.88 | 1.91 | 6.72 | Lymphoma (C81-C85,88,90,96) | 3,009 | 9.54 | 3.28 | 5.86 | Kidney (C64-C66,68) | 2,844 | 9.14 | 3.33 | 5.09 | ||
| 10 | Esophagus (C15) | 6,138 | 9.8 | 3.47 | 5.06 | Pancreas (C25) | 2,906 | 9.21 | 3.17 | 5.11 | Cervix (C53) | 2,597 | 8.35 | 3.04 | 5.46 | ||
ASR, age-standardized rates.